612 related articles for article (PubMed ID: 24170744)
21. Use of urinary pregnanediol 3-glucuronide to confirm ovulation.
Ecochard R; Leiva R; Bouchard T; Boehringer H; Direito A; Mariani A; Fehring R
Steroids; 2013 Oct; 78(10):1035-40. PubMed ID: 23831784
[TBL] [Abstract][Full Text] [Related]
22. Urinary progesterone and pregnanediol. Use for monitoring progesterone treatment.
Stanczyk FZ; Gentzschein E; Ary BA; Kojima T; Ziogas A; Lobo RA
J Reprod Med; 1997 Apr; 42(4):216-22. PubMed ID: 9131494
[TBL] [Abstract][Full Text] [Related]
23. Detecting evidence of luteal activity by least-squares quantitative basal temperature analysis against urinary progesterone metabolites and the effect of wake-time variability.
Bedford JL; Prior JC; Hitchcock CL; Barr SI
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):76-80. PubMed ID: 19552997
[TBL] [Abstract][Full Text] [Related]
24. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
25. [Effects of daily consumption of milk powder on menstrual cycles and urine sex hormone concentrations of young women].
Zhang M; Ju J; Wang Z; Wu J; Geng S; Liu J; Yang Y
Wei Sheng Yan Jiu; 2014 Sep; 43(5):754-8. PubMed ID: 25438529
[TBL] [Abstract][Full Text] [Related]
26. A prototype for ovulation detection: pros and cons.
Lasley BL; Shideler SE; Munro CJ
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2003-7. PubMed ID: 1755459
[TBL] [Abstract][Full Text] [Related]
27. Symptothermal and hormonal markers of potential fertility in climacteric women.
Flynn AM; James P; Collins WP; Royston P
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):1987-9. PubMed ID: 1755454
[TBL] [Abstract][Full Text] [Related]
28. High prevalence of subtle and severe menstrual disturbances in exercising women: confirmation using daily hormone measures.
De Souza MJ; Toombs RJ; Scheid JL; O'Donnell E; West SL; Williams NI
Hum Reprod; 2010 Feb; 25(2):491-503. PubMed ID: 19945961
[TBL] [Abstract][Full Text] [Related]
29. Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women.
Direito A; Bailly S; Mariani A; Ecochard R
Fertil Steril; 2013 Jan; 99(1):279-285.e3. PubMed ID: 22999798
[TBL] [Abstract][Full Text] [Related]
30. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
[TBL] [Abstract][Full Text] [Related]
31. A prospective multicentre study to develop universal immunochemical tests for predicting the fertile period in women. World Health Organisation Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
Int J Fertil; 1985; 30(3):18-30. PubMed ID: 2867054
[TBL] [Abstract][Full Text] [Related]
32. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle.
Turok DK; Godfrey EM; Wojdyla D; Dermish A; Torres L; Wu SC
Hum Reprod; 2013 Oct; 28(10):2672-6. PubMed ID: 23945595
[TBL] [Abstract][Full Text] [Related]
33. Reductions in urinary collection frequency for assessment of reproductive hormones provide physiologically representative exposure and mean concentrations when compared with daily collection.
Allaway HC; Williams NI; Mallinson RJ; Koehler K; De Souza MJ
Am J Hum Biol; 2015; 27(3):358-71. PubMed ID: 25353669
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous dosage of oestrone-3-glycuronide and pregnanediol-3-glycuronide in urines to monitor the fertile period in the woman.
Cortesi S; Fortunato A; Marzot E; Soffiati G
Acta Eur Fertil; 1991; 22(1):27-31. PubMed ID: 1746204
[No Abstract] [Full Text] [Related]
35. Algorithms with Area under the Curve for Daily Urinary Estrone-3-Glucuronide and Pregnanediol-3-Glucuronide to Signal the Transition to the Luteal Phase.
Usala SJ; Alliende ME; Trindade AA
Medicina (Kaunas); 2022 Jan; 58(1):. PubMed ID: 35056427
[No Abstract] [Full Text] [Related]
36. Assessing menstrual cycles with urinary hormone assays.
Santoro N; Crawford SL; Allsworth JE; Gold EB; Greendale GA; Korenman S; Lasley BL; McConnell D; McGaffigan P; Midgely R; Schocken M; Sowers M; Weiss G
Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E521-30. PubMed ID: 12441312
[TBL] [Abstract][Full Text] [Related]
37. Monitoring reproductive aging in a 5-year prospective study: aggregate and individual changes in steroid hormones and menstrual cycle lengths with age.
Ferrell RJ; O'Connor KA; RodrÃguez G; Gorrindo T; Holman DJ; Brindle E; Miller RC; Schechter DE; Korshalla L; Simon JA; Mansfield PK; Wood JW; Weinstein M
Menopause; 2005; 12(5):567-77. PubMed ID: 16145311
[TBL] [Abstract][Full Text] [Related]
38. Urinary ovarian and gonadotropin hormone levels in premenopausal women with low bone mass.
Sowers M; Randolph JF; Crutchfield M; Jannausch ML; Shapiro B; Zhang B; La Pietra M
J Bone Miner Res; 1998 Jul; 13(7):1191-202. PubMed ID: 9661084
[TBL] [Abstract][Full Text] [Related]
39. Variation in maternal urinary cortisol profiles across the peri-conceptional period: a longitudinal description and evaluation of potential functions.
Nepomnaschy PA; Salvante KG; Zeng L; Pyles C; Ma H; Blais JC; Wen L; Barha CK
Hum Reprod; 2015 Jun; 30(6):1460-72. PubMed ID: 25904636
[TBL] [Abstract][Full Text] [Related]
40. [Correlation between indicators of the fertile period of the menstrual cycle and ultrasonically-determined ovulation].
Croce P; Quarenghi A; Montanari G; Barbato M; Pravettoni G; Bertolotti G
Minerva Endocrinol; 1989; 14(3):147-52. PubMed ID: 2622425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
